Although there is extensive evidence in the literature demonstrating that IL-1β promotes tumor invasiveness and angiogenesis in vivo [46], direct evidence for the relation between IL-1β levels and tumor progression have not been found. The gene discussed is IL1B; the disease is neoplasm.